Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Ring finger protein 175 pseudogene (ENSG00000275461) is a non-functional DNA segment closely related to the coding gene for Ring finger protein 175 (RNF175). Pseudogenes are classified by their loss of protein-coding capacity due to disabling mutations, truncations, or deletions, and are generally regarded as nonfunctional elements of the genome[2][6]. However, some pseudogenes (in general, not this specific one) may produce regulatory RNA transcripts with potential gene expression regulatory functions (such as acting as competitive endogenous RNAs or interfering with microRNA networks)[2][8]. RNF175, the parent gene, is part of the E3 ubiquitin ligase family, but the pseudogene itself lacks a functional role as an enzyme, receptor, or drug target[1][3][5]. There is no evidence for its use as a therapeutic target, disease biomarker, or direct involvement in human pathology. Most bioinformatics and genetic databases classify it solely as a processed or unitary pseudogene and not a functional gene product.
Not applicable; no evidence for drug targeting or canonical protein function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ring finger protein 175 pseudogene (RNF175 pseudogene).